Effects of insulin-like growth factor-1 on the in vitro maturation of canine oocytes

J Reprod Dev. 2018 Feb 27;64(1):83-88. doi: 10.1262/jrd.2017-145. Epub 2017 Dec 7.

Abstract

The maturation rate of canine oocytes during in vitro maturation (IVM) needs to be improved. The present study was designed to evaluate the effects of insulin-like growth factor-1 (IGF-1) on the IVM of canine oocytes. Ovaries were obtained by ovariohysterectomy and were sliced to release cumulus-oocyte complexes (COCs). In Experiment 1, the effects of different concentrations of IGF-1 on the nuclear maturation of oocytes was investigated. The COCs were cultured in a modified medium (mTCM199) with IGF-1 (0, 0.5, 5, 10, and 50 µg/ml). At the end of the 48 h culture, oocytes were fixed and stained to evaluate their nuclear stage. Supplementation with 50 µg/ml IGF-1 induced a significantly higher metaphase II (MII) rate (P < 0.05) compared to the 0 and 0.5 μg/ml IGF-1 groups. In Experiment 2, the expression levels of insulin receptor (INSR), IGF-1 receptor (IGF-1R), and IGF-2 receptor (IGF-2R) genes, localized to canine oocytes and cumulus cells, were investigated before and after IVM. The expression level of IGF-1R in cumulus cells after IVM was higher than that before IVM (P < 0.05). In Experiment 3, it was investigated whether an inhibitor of PTEN (phosphatase and tensin homolog), bpV, affects the nuclear maturation of oocytes. Regardless of bpV supplementation at a concentration of 0.2 to 200 µmol/l, there was no significant difference in the proportion of oocytes that reached the MII stage. These results indicated that IGF-1 has a favorable effect on the IVM of canine oocytes, possibly through the stimulation of the Ras/MAPK pathway via IGF-1R expressed in cumulus cells.

Keywords: Canine oocyte; In vitro maturation; Insulin-like growth factor-1 (IGF-1); Insulin-like growth factor-1 receptor (IGF-1R); bpV.

MeSH terms

  • Animals
  • Cumulus Cells / drug effects*
  • Dogs
  • Female
  • In Vitro Oocyte Maturation Techniques / veterinary*
  • Insulin-Like Growth Factor I / pharmacology*
  • Oocytes / drug effects*
  • Ovarian Follicle / drug effects

Substances

  • Insulin-Like Growth Factor I